Histogen Inc.Histogen Inc.Histogen Inc.

Histogen Inc.

No trades
See on Supercharts
Market capitalization
‪2.14 M‬USD
−2.8974USD
‪−10.62 M‬USD
‪3.77 M‬USD
‪4.15 M‬
Beta (1Y)
1.48

About Histogen Inc.

CEO
Susan A. Knudson
Headquarters
San Diego
Employees (FY)
7
Founded
2005
ISIN
US43358Y2028
FIGI
BBG004PP0604
Histogen, Inc. engages in the development of potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. It focuses on Human Multipotent Cell Conditioned Media, Human Extracellular Matrix, and Hair Stimulating Complex. The company was founded by Steven J. Mento and Gail K. Naughton on July 13, 2005 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HSTO is 0.1501 USD — it has decreased by 69.98% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Histogen Inc. stocks are traded under the ticker HSTO.
Histogen Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
HSTO stock is 898.00% volatile and has beta coefficient of 1.48. Check out the list of the most volatile stocks — is Histogen Inc. there?
HSTO earnings for the last quarter are −0.70 USD per share, whereas the estimation was −1.11 USD resulting in a 36.94% surprise. The estimated earnings for the next quarter are −0.76 USD per share. See more details about Histogen Inc. earnings.
Histogen Inc. revenue for the last quarter amounts to ‪495.00 K‬ USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪500.00 K‬ USD.
Yes, you can track Histogen Inc. financials in yearly and quarterly reports right on TradingView.
HSTO stock has fallen by 69.98% compared to the previous week, the month change is a 54.52% fall, over the last year Histogen Inc. has showed a 85.57% decrease.
HSTO net income for the last quarter is ‪−3.85 M‬ USD, while the quarter before that showed ‪−2.09 M‬ USD of net income which accounts for −84.08% change. Track more Histogen Inc. financial stats to get the full picture.
No, HSTO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HSTO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Histogen Inc. stock right from TradingView charts — choose your broker and connect to your account.
HSTO reached its all-time high on May 27, 2020 with the price of 105.2440 USD, and its all-time low was 0.2750 USD and was reached on Dec 28, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 7.00 employees. See our rating of the largest employees — is Histogen Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Histogen Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Histogen Inc. stock shows the sell signal. See more of Histogen Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Histogen Inc. EBITDA is ‪−11.91 M‬ USD, and current EBITDA margin is −278.67%. See more stats in Histogen Inc. financial statements.